Ghrelin receptor: high constitutive activity and methods for developing inverse agonists
- PMID:21050913
- DOI: 10.1016/B978-0-12-381296-4.00006-3
Ghrelin receptor: high constitutive activity and methods for developing inverse agonists
Abstract
The ghrelin receptor is a G protein-coupled receptor (GPCR) mainly distributed in the brain, and also expressed in peripheral tissues. Remarkably, the ghrelin receptor possesses a naturally high constitutive activity representing 50% of its maximal activity. Its endogenous ligand ghrelin is the only known orexigenic gastrointestinal peptide and plays a central role in the regulation of appetite, food intake, and energy homeostasis. Reducing the constitutive activity of the ghrelin receptor by inverse agonists is the strategy adopted by our group to develop anti-obesity drugs. Therefore, short peptides were synthesized and showed high inverse agonist potency toward the ghrelin receptor. This review describes the methods used to synthesize the peptides and to evaluate their biological activity. Peptide synthesis was performed on solid phase using a Fmoc/tBu-strategy. Peptide potency was measured with a signal transduction assay, the inositol trisphosphate turnover assay, adapted to a receptor expressing constitutive activity.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
- Modulation of the constitutive activity of the ghrelin receptor by use of pharmacological tools and mutagenesis.Mokrosiński J, Holst B.Mokrosiński J, et al.Methods Enzymol. 2010;484:53-73. doi: 10.1016/B978-0-12-381298-8.00003-4.Methods Enzymol. 2010.PMID:21036226
- Design, evaluation, and comparison of ghrelin receptor agonists and inverse agonists as suitable radiotracers for PET imaging.Chollet C, Bergmann R, Pietzsch J, Beck-Sickinger AG.Chollet C, et al.Bioconjug Chem. 2012 Apr 18;23(4):771-84. doi: 10.1021/bc2005889. Epub 2012 Mar 20.Bioconjug Chem. 2012.PMID:22372770
- Ghrelin--a novel generation of anti-obesity drug: design, pharmacomodulation and biological activity of ghrelin analogues.Chollet C, Meyer K, Beck-Sickinger AG.Chollet C, et al.J Pept Sci. 2009 Nov;15(11):711-30. doi: 10.1002/psc.1177.J Pept Sci. 2009.PMID:19787814Review.
- High constitutive signaling of the ghrelin receptor--identification of a potent inverse agonist.Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW.Holst B, et al.Mol Endocrinol. 2003 Nov;17(11):2201-10. doi: 10.1210/me.2003-0069. Epub 2003 Aug 7.Mol Endocrinol. 2003.PMID:12907757
- The ghrelin/obestatin balance in the physiological and pathological control of growth hormone secretion, body composition and food intake.Hassouna R, Zizzari P, Tolle V.Hassouna R, et al.J Neuroendocrinol. 2010 Jul;22(7):793-804. doi: 10.1111/j.1365-2826.2010.02019.x. Epub 2010 May 6.J Neuroendocrinol. 2010.PMID:20456603Review.
Cited by
- Taking two to tango: a role for ghrelin receptor heterodimerization in stress and reward.Schellekens H, Dinan TG, Cryan JF.Schellekens H, et al.Front Neurosci. 2013 Aug 30;7:148. doi: 10.3389/fnins.2013.00148.Front Neurosci. 2013.PMID:24009547Free PMC article.Review.
- Promiscuous dimerization of the growth hormone secretagogue receptor (GHS-R1a) attenuates ghrelin-mediated signaling.Schellekens H, van Oeffelen WE, Dinan TG, Cryan JF.Schellekens H, et al.J Biol Chem. 2013 Jan 4;288(1):181-91. doi: 10.1074/jbc.M112.382473. Epub 2012 Nov 16.J Biol Chem. 2013.PMID:23161547Free PMC article.
- Ghrelin protects against renal damages induced by angiotensin-II via an antioxidative stress mechanism in mice.Fujimura K, Wakino S, Minakuchi H, Hasegawa K, Hosoya K, Komatsu M, Kaneko Y, Shinozuka K, Washida N, Kanda T, Tokuyama H, Hayashi K, Itoh H.Fujimura K, et al.PLoS One. 2014 Apr 18;9(4):e94373. doi: 10.1371/journal.pone.0094373. eCollection 2014.PLoS One. 2014.PMID:24747517Free PMC article.
- Automated solid-phase peptide synthesis to obtain therapeutic peptides.Mäde V, Els-Heindl S, Beck-Sickinger AG.Mäde V, et al.Beilstein J Org Chem. 2014 May 22;10:1197-212. doi: 10.3762/bjoc.10.118. eCollection 2014.Beilstein J Org Chem. 2014.PMID:24991269Free PMC article.Review.
- Peptide mini-scaffold facilitates JNK3 activation in cells.Zhan X, Stoy H, Kaoud TS, Perry NA, Chen Q, Perez A, Els-Heindl S, Slagis JV, Iverson TM, Beck-Sickinger AG, Gurevich EV, Dalby KN, Gurevich VV.Zhan X, et al.Sci Rep. 2016 Feb 12;6:21025. doi: 10.1038/srep21025.Sci Rep. 2016.PMID:26868142Free PMC article.
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources